Medizin 2020 in Stuttgart, Germany
Auf der Medizin 2020 vom 7. bis 9. Februar 2020 hat der Verein einen gemeinsamen Verstand mit dem Senior Experten Service (SES Bonn) mit dem er auf seinen Auslandseinsätzen kooperiert…
Nonprofit organization Waisenmedizin looking for supporters
Freiburg non-profit organization could cure disfiguring tropical skin disease – if it had enough money The non-profit organization Waisenmedizin e.V from Freiburg helps poor people who suffer from an infected…
Revival of our former cooperation with Mazar-e-Sharif
July 24th, 2019: The German-Afghan vascular surgeon, Senior Physician Dr. med. Arsalan Asadi of the Johannes Wesling Klinikum Minden and University Hospital of the Ruhr-Universität Bochum, who wants to revive…
“A sting with evil consequences”
On January 24, 2019, the regional newspaper “Badische Zeitung” titled: “Freiburg physicians are committed to Leishmania patients – until the development of a medical device“. 44 readers donated a four-digit…
ystral supports our fight against a neglected tropical skin disease, a laudable gesture that we hope other donors will follow
On September 3, 2018, the owner-managed medium-sized family business ystral, a think tank for process engineering based in Ballrechten-Dottingen near Freiburg, Germany, donated a Conti-TDS mixer with a new purchase…
Give Hope Now to Patients with Skin NTDs in the Middle East and Africa
On August 30th, 2017, the German Regulatory Drug and Medical Device Agency, BfArM, has granted a special approval, i.e. a temporary market access for the wound healing device LeiProtect®, developed…
Agreement of Scientific Cooperation
Waisenmedizin e.V. Freiburg and the Algerian Pasteur Institute (API) have signed an agreement of scientific cooperation (Convention particulière portant sur le projet “Contrôle de la Leishmaniose Cutanée en Algérie du…
Hand-Hygiene Propagation in the biggest MENA country, Algeria
Together with the Directorate-General of Prevention and Health Promotion at the Algerian Ministry of Health, Prof. Zoubir Harrat, Director-General of the Institut Pasteur d’Algérie (IPA), is committed to effectively propagating hand…
Temporary Market Access granted by BfArM for the Medical Device, LeiProtect®
The use of LeiProtect® has been legalized on August 28th, 2017 (91.1.07-5640-S-006/16) by the Institut für Arzneimittel und Medizinprodukte (BfArM) according to § 11 of the Medical Device Regulation (MPG)….